SomaLogic announced that the Massachusetts General Hospital will this fall begin offering access to the company's Somascan assay.
Based on SomaLogic's somamer affinity reagents, the Somascan platform allows for simultaneous quantification of 1,129 proteins.
NEW YORK (GenomeWeb News) – Somalogic said this week that it has received additional funding from the Bill & Melinda Gates Foundation for the development and validation of tuberculosis biomarker assays based on its Somamer technology.
While its diagnostic ambitions continue to progress slowly, proteomics firm Somalogic appears to be carving out a substantial market for its SOMAscan protein biomarker discovery platform, generating $10.5 million in revenues from the product in 2013.
SAN FRANCISCO (GenomeWeb News) – The 32nd Annual JP Morgan Healthcare Conference kicked off here Monday with several life science tools and diagnostic firms making presentations to investors and other attendees.
SomaLogic has named Byron Hewett as CEO. Hewett takes replaces Larry Gold, who will continue serving the Boulder, Colo.-based company as chairman of the board. Gold will also work as a full-time adviser, SomaLogic said.